Generic Imitrex approval
This article was originally published in The Tan Sheet
Executive Summary
FDA grants Teva Pharmaceuticals tentative approval for a generic version of GlaxoSmithKline's migraine treatment Imitrex Nov. 29. Final approval of the 25 mg, 50 mg and 100 mg Sumatriptan Succinate Tablets is expected upon expiry of patent protection in February 2009, according to the Jerusalem-based company. In October, Dr. Reddy's announced it will launch an "authorized" generic version of the drug in Q4 2008 (1"The Tan Sheet" Oct. 16, 2006, In Brief)...